Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH.

Cell. 2012 Feb 3;148(3):421-33. doi: 10.1016/j.cell.2012.01.017.

2.

Resveratrol as a calorie restriction mimetic: therapeutic implications.

Chung JH, Manganiello V, Dyck JR.

Trends Cell Biol. 2012 Oct;22(10):546-54. doi: 10.1016/j.tcb.2012.07.004. Review.

3.

Metabolic effects of resveratrol: addressing the controversies.

Bitterman JL, Chung JH.

Cell Mol Life Sci. 2015 Apr;72(8):1473-88. doi: 10.1007/s00018-014-1808-8. Review.

PMID:
25548801
4.

Implications of PDE4 structure on inhibitor selectivity across PDE families.

Ke H.

Int J Impot Res. 2004 Jun;16 Suppl 1:S24-7. Review.

PMID:
15224132
6.

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C.

J Biol Chem. 2003 Feb 21;278(8):5493-6. Review. No abstract available.

7.

Phosphodiesterase-4 as a potential drug target.

Zhang KY, Ibrahim PN, Gillette S, Bollag G.

Expert Opin Ther Targets. 2005 Dec;9(6):1283-305. Review.

PMID:
16300476
8.

Phosphodiesterase inhibitors in airways disease.

Fan Chung K.

Eur J Pharmacol. 2006 Mar 8;533(1-3):110-7. Review.

PMID:
16458289
9.

Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4).

O'Donnell JM, Zhang HT.

Trends Pharmacol Sci. 2004 Mar;25(3):158-63. Review. No abstract available.

PMID:
15019272
10.

Resveratrol vs. calorie restriction: data from rodents to humans.

Lam YY, Peterson CM, Ravussin E.

Exp Gerontol. 2013 Oct;48(10):1018-24. doi: 10.1016/j.exger.2013.04.005. Review.

PMID:
23624181
11.

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases.

Souness JE, Rao S.

Cell Signal. 1997 May-Jun;9(3-4):227-36. Review.

PMID:
9218122
12.

The journey of resveratrol from yeast to human.

Timmers S, Auwerx J, Schrauwen P.

Aging (Albany NY). 2012 Mar;4(3):146-58. Review.

13.

Calorie restriction and resveratrol in cardiovascular health and disease.

Dolinsky VW, Dyck JR.

Biochim Biophys Acta. 2011 Nov;1812(11):1477-89. doi: 10.1016/j.bbadis.2011.06.010. Review.

Items per page

Supplemental Content

Support Center